Medication Adherence as Plaintiff Credibility Evidence: A Clinical Pearl for PI Attorneys

Amar Lunagaria — Co-Founder & Chief Pharmacist, LienScripts | March 4, 2026 | 9 min read

A plaintiff who consistently fills and takes prescribed medications demonstrates credibility, compliance, and genuine need. Learn how medication adherence documented in pharmacy records serves as powerful credibility evidence that counters defense attacks on the plaintiff's truthfulness and commitment to recovery.

Medication adherence -- the consistent, timely filling and taking of prescribed medications -- is one of the strongest credibility indicators available in personal injury litigation. A plaintiff who fills every prescription on schedule, maintains a consistent refill pattern over months or years, and complies with a complex medication regimen is demonstrating through documented behavior that their condition is real, their pain is genuine, and their commitment to recovery is beyond reproach. This behavioral evidence, captured objectively in pharmacy records, is the antidote to nearly every credibility attack that defense counsel deploys.

  • Medication adherence documented by pharmacy fill records is objective behavioral evidence of plaintiff credibility that defense counsel cannot dismiss as self-serving
  • Consistent refill patterns prove the plaintiff is following medical advice, taking prescribed medications, and actively participating in their recovery
  • LienScripts tracks every dispense and refill, generating a MERIT (Medication Evaluation & Rationale for Injury Treatment) report that documents adherence patterns for each medication
  • High adherence rates undermine defense arguments that the plaintiff is exaggerating, malingering, or failing to mitigate damages
  • Medication adherence data transforms pharmacy records from billing documentation into character evidence

Why Adherence Equals Credibility

In every personal injury case, the plaintiff's credibility is contested. Defense counsel will argue that the plaintiff is exaggerating pain, inflating damages, malingering, or failing to pursue recovery. These attacks target the plaintiff's character and truthfulness -- and they are effective when the plaintiff's evidence is primarily self-reported.

Medication adherence provides an objective counter-narrative. A plaintiff who:

  • Fills their gabapentin every 28-30 days for 14 months without missing a cycle
  • Picks up their muscle relaxant on schedule despite the inconvenience of pharmacy visits
  • Maintains a multi-drug regimen requiring different refill dates and dosing schedules
  • Continues filling medications even when the case is not yet near settlement

...is demonstrating through behavior, not words, that they genuinely need these medications and are doing everything the medical system asks of them.

As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist explains, "In clinical pharmacy, we know that medication adherence rates in the general population hover around 50% for chronic medications. A personal injury plaintiff who maintains 90% or higher adherence over 12-plus months is not only demonstrating genuine need -- they are outperforming the average patient by a wide margin. That level of compliance is powerful behavioral evidence of a person who is taking their condition and their recovery seriously."

Measuring Adherence in Pharmacy Records

Medication Possession Ratio (MPR)

The Medication Possession Ratio is the standard measure of adherence. It calculates the percentage of days during a treatment period that the patient had medication available based on fill dates and days supply:

MPR = (Total days supply dispensed / Total days in treatment period) x 100

An MPR of 80% or higher is considered adherent in clinical literature. Personal injury plaintiffs who maintain MPRs above 90% demonstrate exceptional compliance.

For example, a plaintiff prescribed gabapentin with a treatment period of 365 days who received fills totaling 340 days supply has an MPR of 93%. This means the plaintiff had medication available on 93% of treatment days -- a level of adherence that is above the clinical threshold and above the general population average.

Proportion of Days Covered (PDC)

PDC is a more refined measure that accounts for overlapping fills. It calculates the percentage of days in the measurement period that the patient had at least one day's supply of medication on hand. PDC penalizes stockpiling (filling early but not actually taking the medication) less than MPR, but for most personal injury cases, the two measures yield similar results.

Practical Assessment

Even without calculating formal ratios, the refill pattern tells the adherence story. Consistent fills at regular intervals (every 28-30 days for a 30-day supply) indicate high adherence. Large gaps between fills suggest non-adherence or interruptions. Pharmacy records from LienScripts display the fill history in chronological order, making visual assessment of adherence straightforward.

Adherence as Rebuttal Evidence

Rebutting "The Plaintiff Is Exaggerating"

Defense counsel frequently argues that the plaintiff is exaggerating symptoms to inflate damages. Medication adherence directly contradicts this argument. A plaintiff who consistently fills and takes medications for over a year is not performing for the litigation -- they are treating a genuine medical condition. The adherence behavior predates, continues through, and will likely continue after the litigation. It is not strategic; it is medical.

Rebutting "The Plaintiff Is Malingering"

Malingering -- the intentional fabrication or exaggeration of symptoms for secondary gain -- is a serious accusation that defense medical examiners sometimes suggest. High medication adherence makes this accusation difficult to sustain. A malingerer would be unlikely to maintain a complex medication regimen with 90%+ adherence over many months. The cost, inconvenience, and side effect burden of genuine medication compliance is a strong indicator that the plaintiff's condition is real.

Rebutting "The Plaintiff Failed to Mitigate Damages"

The failure-to-mitigate defense argues that the plaintiff did not take reasonable steps to minimize their damages. High medication adherence is the definitive rebuttal. The plaintiff followed every prescription, filled every medication, and maintained their regimen as directed. They could not have done more to mitigate their damages from a pharmacological standpoint. The pharmacy record proves compliance with medical advice.

Rebutting "The Plaintiff Is Not Really In Pain"

If the plaintiff were not in pain, they would stop filling pain medications. The clinical literature consistently shows that patients who do not need medications stop taking them -- medication non-adherence is one of the most documented phenomena in healthcare. A plaintiff who continues to fill pain medications month after month is behavioral proof that the medications provide necessary relief from genuine pain.

Presenting Adherence Evidence in Demand Packages

The Adherence Summary

Include a medication adherence section in every demand package that presents:

  1. Each medication with its prescribed frequency and expected refill interval
  2. Total fills during the treatment period versus expected fills
  3. Adherence rate (MPR or PDC) for each medication
  4. Comparison to population norms -- noting that the plaintiff's adherence exceeds the general population average of approximately 50%
  5. Interpretation -- stating that the plaintiff's adherence demonstrates genuine medical need and commitment to recovery

Visual Presentation

A refill timeline showing consistent, on-schedule fills is one of the most visually compelling exhibits in a demand package. Each fill marker at regular intervals creates a visual pattern that communicates compliance, consistency, and commitment. The MERIT report from LienScripts presents this refill chronology in a format designed for non-clinical audiences.

Adherence in Multi-Drug Regimens

Adherence evidence becomes even more powerful when the plaintiff is managing multiple concurrent medications. Maintaining high adherence across a polypharmacy regimen -- filling five or six medications on different schedules, managing different quantities and days supplies, coordinating refills across multiple prescriptions -- demonstrates a level of medical engagement that is inconsistent with exaggeration or malingering.

A plaintiff who maintains 85%+ adherence across five concurrent medications is investing significant time, effort, and organization into their medical care. This is the behavior of someone who genuinely needs these medications and is committed to their recovery, not someone who is gaming the system.

The Bottom Line

Medication adherence is credibility evidence hiding in plain sight in every pharmacy record. Attorneys who recognize and present adherence data transform routine dispensing records into character evidence that undermines the most common defense attacks on plaintiff credibility. When the pharmacy record shows a plaintiff who filled every prescription, on schedule, for months or years, the behavioral message is unmistakable: this plaintiff's condition is real, their treatment is necessary, and their commitment to recovery is genuine.

LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report for every case, providing pharmacist-signed documentation for demand packages that includes adherence analysis as part of the comprehensive clinical narrative.

Related Resources

Frequently Asked Questions

How does medication adherence serve as credibility evidence in PI cases?

Medication adherence documented by pharmacy fill records is objective behavioral evidence that the plaintiff's condition is genuine. A plaintiff who consistently fills prescriptions on schedule for months or years is demonstrating through behavior -- not words -- that they need the medications. This undercuts defense arguments of exaggeration, malingering, or failure to mitigate damages.

How is medication adherence measured in pharmacy records?

The standard measure is the Medication Possession Ratio (MPR): total days supply dispensed divided by total days in the treatment period, multiplied by 100. An MPR of 80% or higher is considered adherent in clinical literature. Proportion of Days Covered (PDC) is a more refined alternative. Both can be calculated from pharmacy fill dates and days supply data available in dispensing records.

Why does high adherence undermine the malingering defense?

Malingering involves intentional fabrication of symptoms for secondary gain. A malingerer would be unlikely to maintain a complex medication regimen with 90%+ adherence over many months because of the cost, inconvenience, and genuine side effect burden of taking multiple medications. Sustained high adherence is behavioral evidence that the plaintiff's condition is real and they are genuinely committed to their medical treatment.